Medical Devices UK

UK Newborn Screening Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

UK Newborn Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

UK · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $29.2 Mn Placeholder estimate
Estimate 2025 $31.3 Mn 2.6% of the global market
Projected 2034 $58.1 Mn 85.4% Adds $26.7 Mn over 9 forecast years
CAGR 2025–2034 7.1% Faster than 53% of 173 Medical Devices markets here
Key players 5
  • UK is 2.64% of the global market.
  • In Europe, the largest is Germany at $39.8 Mn.
  • Fastest growing: Russia at 9.4% a year.
  • UK ranks 2nd of 6 by size in Europe.

Market size projection

UK

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$26.7 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Newborn Screening Market market size by year, UK
YearMarket sizeChange that yearSince 2025
2024 (estimate) $29.2 Mn — —
2025 (base) $31.3 Mn +$2.1 Mn —
2026 (forecast) $33.5 Mn +$2.2 Mn +7.1%
2027 (forecast) $35.9 Mn +$2.4 Mn +14.7%
2028 (forecast) $38.5 Mn +$2.6 Mn +22.8%
2029 (forecast) $41.2 Mn +$2.7 Mn +31.6%
2030 (forecast) $44.1 Mn +$2.9 Mn +40.9%
2031 (forecast) $47.3 Mn +$3.1 Mn +50.9%
2032 (forecast) $50.6 Mn +$3.4 Mn +61.6%
2033 (forecast) $54.2 Mn +$3.6 Mn +73.1%
2034 (forecast) $58.1 Mn +$3.8 Mn +85.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.19 Bn
  2. North America $567.9 Mn
  3. US $459.4 Mn
  4. Europe $219.2 Mn
  5. APAC $219.1 Mn
  6. Canada $102.6 Mn
  7. China $90.1 Mn
  8. Japan $85.7 Mn
  9. Latin America $58.8 Mn
  10. Middle East $47.7 Mn
  11. Germany $39.8 Mn
  12. UK (this report) $31.3 Mn
  13. Brazil $31.6 Mn
  14. Italy $30.5 Mn
  15. France $28.9 Mn
  16. Saudi Arabia $23.7 Mn
  17. Ecuador $22.7 Mn
  18. Spain $20.0 Mn
  19. Africa $20.5 Mn
  20. India $19.9 Mn
  21. Mexico $15.6 Mn
  22. Australia $13.7 Mn
  23. New Zealand $12.6 Mn
  24. Russia $10.8 Mn
  25. South Africa $8.6 Mn
  26. UAE $5.4 Mn
  27. Egypt $3.1 Mn
  28. Philippines $2.5 Mn
  29. Malaysia $2.2 Mn
  30. Hong Kong $1.7 Mn
  31. Singapore $1.6 Mn
  32. Thailand $1.4 Mn
  33. Kenya $0.9 Mn

Report snapshot

UK Newborn Screening Market Analysis at a glance
Market size, 2025$31.3 Mn placeholder estimate
Forecast, 2034$58.1 Mn placeholder estimate
Growth (CAGR), 2025–20347.1% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, technology and end user (see all)
Key playersRevvity, Natus Medical, Trivitron Healthcare, Bio-Rad Laboratories, Masimo Corporation (see all)
Regulator in the UKMHRASource: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The UK Newborn Screening Market Analysis Executive Summary

Newborn screening tests babies shortly after birth for rare but serious conditions such as metabolic, hormone and genetic disorders.

Key segments of the newborn Screening market include test (Dried Blood Spot Tests, Hearing Screening and Pulse Oximetry) and technology (Tandem Mass Spectrometry, Immunoassays and DNA Assays).

Bar chart: UK Newborn Screening market size, 2024–2034, placeholder estimates. $29.2 Mn in 2024, $31.3 Mn in 2025 and $58.1 Mn in 2034, 7.1% CAGR.
UK Newborn Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

UK Newborn Screening Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the newborn Screening market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the newborn Screening market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the newborn Screening market.

Competitive Landscape for Newborn Screening Market in UK

The newborn Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Newborn Screening Market in UK

Newborn Screening in the UK: rules, payment and health figures

Medical devices sold in Great Britain need UKCA or CE marking and registration with the Medicines and Healthcare products Regulatory Agency (MHRA).⁠[1] The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund.⁠[2] Newborn deaths (first 28 days): 3.0 per 1,000 live births in 2024, the latest WHO figure for the UK.⁠[3]

[1] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[2] National Institute for Health and Care Excellence. Checked 14 Nov 2026.

[3] WHO Global Health Observatory, Newborn deaths (first 28 days) (per 1,000 live births). Retrieved 15 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how newborn Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in UK.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Newborn Screening right now, from free public sources.

Latest research 3,809 papers since 2021 (worldwide)

  1. Early-onset epilepsy and inborn errors of metabolism: A large retrospective pediatric cohort. Epilepsy & behavior : E&B, 2026
  2. [Newborn screening in Spain: equity, clinical value and challenges in the context of technological expansion]. Revista espanola de salud publica, 2026
  3. Regional newborn screening for Gaucher disease in Kumamoto and Fukuoka Prefectures, Japan: an updated report and long-term outcomes of screen-identified patients. Molecular genetics and metabolism, 2026
  4. Newborn Screening for Duchenne Muscular Dystrophy: Contemporary Considerations for Implementation of an Early Diagnostic Paradigm. Neurology, 2026
  5. Cystic fibrosis: remarkable success but still not at the finish line. Proceedings (Baylor University. Medical Center), 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Newborn Screening in context

The UK compared

  • Newborn deaths (first 28 days): 3.0 per 1,000 live births (2024). World: 17.2 per 1,000 live births (2024). Highest of the 6 countries we cover in Europe.[1]
  • Health spending per person: 5,860 US$ per person (2024). World: 1,317 US$ per person (2023). 2nd highest of the 6 countries we cover in Europe.[2]
  • Doctors: 3.30 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 5th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Newborn deaths (first 28 days) (per 1,000 live births). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Newborn Screening market in the UK?
Placeholder estimate: about $31.3 Mn in 2025, rising to about $58.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Newborn Screening market in the UK growing?
Placeholder estimate: about 7.1% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Newborn Screening market report cover?
The report splits the market by test (Dried Blood Spot Tests, Hearing Screening, Pulse Oximetry, Genomic Screening), technology (Tandem Mass Spectrometry, Immunoassays, DNA Assays) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Newborn Screening market?
Key players include Revvity, Natus Medical, Trivitron Healthcare, Bio-Rad Laboratories and Masimo Corporation.
What is driving the Newborn Screening market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the newborn Screening market.
Who regulates Newborn Screening in the UK?
Medical devices sold in Great Britain need UKCA or CE marking and registration with the Medicines and Healthcare products Regulatory Agency (MHRA). Source: Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
How is healthcare paid for in the UK?
The NHS gives care that is free at the point of use; in England, NICE advises which medicines and treatments the NHS should fund. Source: National Institute for Health and Care Excellence. Checked 14 Nov 2026.
What does WHO report for the UK?
Newborn deaths (first 28 days): 3.0 per 1,000 live births in 2024, the latest WHO figure. Source: WHO Global Health Observatory, Newborn deaths (first 28 days) (per 1,000 live births). Retrieved 15 Nov 2026.
How many people in the UK are 65 or older?
19.7% of people were 65 or older in 2025. Source: World Bank Open Data, Population ages 65 and above (% of total population), from UN population estimates. Retrieved 15 Nov 2026.
How much research is published on Newborn Screening?
PubMed lists 3,809 papers on Newborn Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Newborn Screening in UK? Our analysts can size it for your plan. Talk to us See the public data Newborn deaths (first 28 days) for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in UK

See all
Same topic, other categories

Related on diagnostics and lab testing and neonatal

See the topic